Celsion (CLSN) Issues Letter to Stockholders

Go back to Celsion (CLSN) Issues Letter to Stockholders

Celsion Corporation Issues Letter to Stockholders

October 12, 2020 8:01 AM EDT

CEO Provides Updates on Phase III OPTIMA Study Data Analysis and ThermoDox® Investigator-Sponsored Studies

LAWRENCEVILLE, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Michael H. Tardugno,... More